Company Profile

ATLAS Biolabs GmbH is a leading provider of complex analyses in molecular genetics including microarray-based genomic services, targeted sequence capture, and next-generation sequencing. ATLAS Biolabs performs genome-wide gene expression and SNP analyses, array CGH, comprehensive mutation profiling and next-generation sequencing for academic institutions, pharmaceutical and biotechnological enterprises, as well as for clinicians and registered doctors. Expert data processing and bioinformatics capabilities ensure a high added value to the data generated in its laboratories and highly flexible service options for different customer needs.

History

ATLAS Biolabs is a privately owned company (GmbH). It was founded by leading genome researchers from Germany as a spin-off from both the RZPD German Resource Center for Genome Research and the Cologne Center for Genomics (CCG). ATLAS Biolabs started its business operations in August 2007 in the centre of Berlin, Germany.

Excellence

ATLAS Biolabs is a Certified Affymetrix, Agilent and NimbleGen Service Provider.
ATLAS Biolabs’ management team and technical staff combine many years of in-depth experience in various fields of molecular biology and bioinformatics, including microarray technologies, microarray data analysis, and molecular diagnostics.
ATLAS Biolabs has successfully managed numerous large national and international microarray projects for both academic and industrial customers.
ATLAS Biolabs is certified according to the international standard DIN EN ISO 9001:2008 and EN ISO 13485:2003 + AC:2009. All production processes are subject to rigorous quality control at all steps.

Management

Prof. Dr. Peter Nürnberg, CEO, is an internationally renowned researcher in the field of human genetics and the president of the German Association for Gene Diagnostics (AGD e.V.). He is a full professor of genomics at the University of Cologne and since 2005 the director of the Cologne Center for Genomics (CCG). From 2000 to 2004, he was the Head of the Gene Mapping Center (GMC) at the Max Delbrück Center (MDC) for Molecular Medicine, Berlin-Buch.

Dr. Florian Wagner, Head of Microarray Service Unit, is an expert in the microarray field and has 10 years of experience with all important microarray technologies. He was Head of the Microarray Service Unit at RZPD from 2001 to 2007 and joined ATLAS Biolabs in August 2007.

Dr. Karsten R. Heidtke, Head of Bioinformatics and IT, has long standing experience in leading IT and bioinformatics projects. Before joining ATLAS Biolabs in 2007, he was a Senior Scientist Bioinformatics at RZPD. He headed the Bioinformatics and IT group at Biopsytec GmbH from 2000–2003 after completing his Ph.D. at the Max Planck Institute for Molecular Genetics.

Advisory Board

Prof. Dr. Hans Lehrach is a director at the Max Planck Institute for Molecular Genetics in Berlin-Dahlem and an internationally renowned researcher in the field of vertebrate genomics. He was involved in the international Human Genome Project and has pioneered new applications of novel sequencing technologies.

Prof. Dr. Gundula Thiel is owner and head of a private practice for human genetics in Berlin. She is an expert in clinical genetics and molecular cytogenetics and teaches at the Charité in Berlin.

Dr. Roman Skoblo is founder, owner and CEO of IFLB Institute of Laboratory Diagnostics Berlin, a medical diagnostics laboratory in Berlin.